Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
Pérez-Ruiz, E., Jiménez-Castro, J., Berciano-Guerrero, M.-A., Valdivia, J., Estalella-Mendoza, S., Toscano, F., Rodriguez de la Borbolla Artacho, M., Garrido-Siles, M., MartÃnez-Bautista, M. J., ViLanguage:
english
Journal:
Clinical and Translational Oncology
DOI:
10.1007/s12094-020-02315-9
Date:
February, 2020
File:
PDF, 796 KB
english, 2020